Escape of Candida from Caspofungin Inhibition at Concentrations above the MIC (Paradoxical Effect) Accomplished by Increased Cell Wall Chitin; Evidence for β-1,6-Glucan Synthesis Inhibition by Caspofungin
Open accessAbstract
Concentrations above the MIC of caspofungin allow growth of some Candida isolates. A strain demonstrating paradoxical growth was grown in the presence and absence of caspofungin, and the cell wall content was analyzed. Beta-1,3-glucan declined 81% in the presence of caspofungin, as expected. Beta-1,6-glucan declined 73%. Chitin increased 898%, demonstrating a mechanism for paradoxical growth-a rapid shift in the key polymer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A reduction in β-1,6-glucan level has been reported in the literature for C. albicans during caspofungin treatment, along with an increase in the molecular size of β-1,6-glucan and cross-linking of glucan and chitin.
“In addition to the inhibition of the biosynthesis of the primary target, β-1,3-glucan, a reduction in β-1,6-glucan level has also been reported in the literature for C. albicans during caspofungin treatment80, along with an increase in the molecular size of β-1,6-glucan and cross-linking of glucan and chitin36.”
From Distinct echinocandin responses of Candida albicans and Candida auris cell walls revealed by solid-state NMR (2025) · cites this paper as [80]
Induction of the CWI pathway in Candida species, including C. glabrata, has been linked to increased production of chitin, potentially compensating for loss of beta-1,3-glucans.
“Induction of the CWI pathway in Candida species (Stevens et al., 2006; Walker et al., 2013), including C. glabrata (Cota et al., 2008), has been linked to increased production of other cell wall components, such as chitin, potentially compensating for the loss of beta-1,3-glucans.”
From Genetic Drivers of Multidrug Resistance in Candida glabrata (2016) · cites this paper as Stevens et al., 2006
Previous studies have linked the paradoxical effect with cell wall stress responses that permit growth in the presence of high concentrations of CAS, such as upregulation of chitin biosynthesis, high-osmolarity glycerol responses and calcium/calcineurin signalling pathways.
“Previous studies have linked the paradoxical effect with cell wall stress responses that permit growth in the presence of high concentration of CAS, such as upregulation of chitin biosynthesis, high-osmolarity glycerol responses and calcium/calcineurin signalling pathways [14].”
From In vitro analysis of flufenamic acid activity against Candida albicans biofilms (2014) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 15 · Cited by 193
Research works printed but not linked: 1
- [5]Deresinski, S. C., and D. A. Stevens. 2003. Caspofungin. Clin. Infect. Dis. 36:1445-1457. [DOI] [PubMed] [Google Scholar]
- Authors
- Stevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H.
- Affiliations
- Santa Clara Valley Medical Center (US)
- The University of Tokyo (JP)
- Corresponding author
- Stevens, David A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-09
- Volume
- 50
- Issue
- 9
- Pages
- 3160-3161
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1563524
- OpenAlex
- W2152485629
- Cited by
- 193
- References
- 15
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 7 · 2019: 4 · 2018: 9 · 2017: 11 · 2016: 7 · 2015: 15 · 2014: 8 · 2013: 14 · 2012: 11
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Keywords
- caspofungin, Candida, chitin, β-1,6-glucan, β-1,3-glucan, cell wall, antifungal resistance, fungal cell wall biosynthesis
- MeSH terms
- Caspofungin, Antifungal Agents, Candida albicans, Cell Wall, Chitin, Microbial Sensitivity Tests, Peptides, Cyclic, beta-Glucans, Echinocandins, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review